"Thank you to everyone who gives blood. It helped save my life." The post Boy with rare blood disorder saved by 23 donors ...

Acquiring Vega Therapeutics, an offshoot of "hub-and-spoke" biotech Star Therapeutics, would give Incyte a medicine that’s in ...

An expert observes a concerning rise in symptoms of bleeding disorders, with nearly 2–3 women reporting every week.

June 8 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer's drug to prevent or reduce the frequency of ...

In what sounds like a horror movie, an 11-year-old Indian boy began inexplicably bleeding out of his eyes, nose and ears.

Incyte Corp. ( INCY) is close to acquiring privately held Star Therapeutics in a deal valued at up to $2 billion, the ...

(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...

Incyte’s Vega Therapeutics acquisition comes with a late-stage drug offering a novel mechanism of action and a dosing ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...